Profound Medical PROF
NASDAQ PROF
$6.79 +0.14 (+2.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

Profound Medical (PROF) Net Cash Flow Growth (1y) (2025 - 2026)

Profound Medical (PROF) Net Cash Flow Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -562.77%
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 2,827.78%
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 10.50%
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -395.56%
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 168.38%
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -103.49%
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -114.85%
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -215.59%
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -54.17%
10 Profound Medical 247.18 Mn 208.91 Mn 1.95 Mn 17.51%

Historic Data

Download Data
DateValue
Jun 30, 2026 17.51%
Mar 31, 2026 -0.12%
Dec 31, 2025 17.95%
Sep 30, 2025 -29.60%
Jun 30, 2025 -101.47%
Mar 31, 2025 -153.83%